Beijing VDJBio (China)
In research, Beijing VDJBio (China) stands highest in Life Sciences (#4,898 of 7,800 worldwide), Health Sciences (#10,099 of 11,982 worldwide) and Medicine (#9,095 of 10,443 worldwide), 2022–2025.
- World rank, 2022–2025
- #11,091 of 28,054 · #20,189 all time
- Rank in China
- #1,979 of 3,058
- Research works
- 375 ▲ 149% vs 2013–17
- Citations
- 3.5k 9.3 per fractional work
- Top-10% rate
- 12.7% record average 16.5%
- Open access
- 42% world 28%
What is Beijing VDJBio (China) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #4,898 of 7,800 | 16.0% | 78 | #8706 | |
| Health SciencesDomain | #10,099 of 11,982 | 9.6% | 80 | #18535 | |
| MedicineField | #9,095 of 10,443 | 8.8% | 76 | #16378 |
Each strip is that field’s whole ranked pool, with the notch where Beijing VDJBio (China) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#8,706 #4,898
- Health Sciences#18,535 #10,099
- Medicine#16,378 #9,095
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.8×. Every wedge is a field page.
- Immunology and Microbiology 5.8×
- Biochemistry, Genetics and Molecular Biology 4.3×
- Pharmacology, Toxicology and Pharmaceutics 3.1×
- Veterinary 2.3×
- Medicine 2.0×
- Nursing 1.7×
- Agricultural and Biological Sciences 1.4×
- Dentistry 1.3×
- Neuroscience 0.9×
- Chemistry 0.8×
- Computer Science 0.6×
- Engineering 0.6×
- Energy 0.5×
- Materials Science 0.4×
- Environmental Science 0.4×
- Decision Sciences 0.3×
- Chemical Engineering 0.2×
- Business, Management and Accounting 0.2×
- Economics, Econometrics and Finance 0.2×
- Earth and Planetary Sciences 0.2×
- Physics and Astronomy 0.1×
- Mathematics 0.1×
- Health Professions 0.0×
- Social Sciences 0.0×
- Arts and Humanities 0.0×
Which keywords describe research at Beijing VDJBio (China)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Cancer, Glycosylation, Monoclonal Antibodies, Tumor Microenvironment, Therapeutic Antibodies, Cancer Immunotherapy and Antibody Engineering.
- Cell Proliferation
- Monoclonal Antibody
- PD-1 and PD-L1
- Viral Vectors
- Angiogenesis
- Vaccine Adjuvants
- Metabolism
- Targeted Therapy
- Antigen Presentation
- Chimeric Antigen Receptor
- Lymphoma
- Gene Therapy
- Immunity
- Tumor Regression
- Cancer Therapy
- Antibody Engineering
- Cancer Immunotherapy
- Tumor Microenvironment
- Epidemiology
- Immunotherapy
- Cancer
- Glycosylation
- Monoclonal Antibodies
- Therapeutic Antibodies
- Inflammation
- Fc Receptors
- Immune Response
- Innate Immunity
- Vaccine
- Chemotherapy
- CAR T Cells
- Pathogenesis
- Genomic Integration
- Dendritic Cells
- Tumor Antigen
- PET Imaging
- AAV
- Immune Checkpoint Blockade
- Coronavirus
- Transcriptional Regulation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer15▲ 5.5×29 topics
- Immunotherapy13▲ 9.0×12 topics
- Glycosylation12▲ 56×3 topics
- Epidemiology12▲ 1.54×41 topics
- Monoclonal Antibodies10▲ 58×3 topics
- Tumor Microenvironment10▲ 12×7 topics
- Therapeutic Antibodies10▲ 72×2 topics
- Cancer Immunotherapy10▲ 31×3 topics
- Inflammation10▲ 2.3×37 topics
- Antibody Engineering9▲ 86×1 topic
- Fc Receptors9▲ 86×1 topic
- Cancer Therapy9▲ 7.5×17 topics
- Immune Response8▲ 7.5×13 topics
- Tumor Regression8▲ 36×2 topics
- Innate Immunity7▲ 11×8 topics
- Immunity7▲ 8.5×7 topics
- Vaccine7▲ 8.3×9 topics
- Gene Therapy7▲ 18×5 topics
- Chemotherapy6▲ 4.2×10 topics
- Lymphoma6▲ 17×2 topics
- CAR T Cells5▲ 36×1 topic
- Chimeric Antigen Receptor5▲ 36×1 topic
- Pathogenesis5▲ 4.9×13 topics
- Antigen Presentation5▲ 26×2 topics
- Genomic Integration5▲ 41×2 topics
- Targeted Therapy5▲ 10×5 topics
- Dendritic Cells4▲ 23×3 topics
- Metabolism4▲ 4.2×17 topics
- Tumor Antigen4▲ 32×1 topic
- Vaccine Adjuvants4▲ 32×1 topic
- PET Imaging4▲ 11×4 topics
- Angiogenesis4▲ 5.6×8 topics
- AAV4▲ 45×1 topic
- Viral Vectors4▲ 45×1 topic
- Immune Checkpoint Blockade3▲ 15×1 topic
- PD-1 and PD-L13▲ 15×1 topic
- Coronavirus3▲ 7.6×2 topics
- Monoclonal Antibody3▲ 29×2 topics
- Transcriptional Regulation3▲ 9.3×6 topics
- Cell Proliferation3▲ 17×3 topics
Which research topics does Beijing VDJBio (China) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Immunotherapy and Immune Responses and Virus-based gene therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 9 works
- 2 CAR-T cell therapy research Oncology 5 works
- 3 Immunotherapy and Immune Responses Immunology 4 works
- 4 Virus-based gene therapy research Genetics 4 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 6 Cancer Research and Treatments Biotechnology 2 works
- 7 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 2 works
- 8 Cancer, Hypoxia, and Metabolism Cancer Research 2 works
- 9 Immune Cell Function and Interaction Immunology 2 works
- 10 Peptidase Inhibition and Analysis Oncology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Beijing VDJBio (China)'s research output changed?
Output in 2018–2022 was 149% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Beijing
- Chinese Academy of Sciences
- Tsinghua University
- Peking University
- University of Chinese Academy of Sciences
- Beihang University
- Beijing Institute of Technology
- Chinese Academy of Medical Sciences & Peking Union Medical College
- North China Electric Power University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.